Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-02 · accession 0001415889-24-000608 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-04 | 2024-01-02 | KNSA | Megna Michael R | CAO | M - OptEx | $13.88 | +16.7K | 33.7K | +98% | +$231.4K |
| D | 2024-01-04 | 2024-01-02 | KNSA | Megna Michael R | CAO | S - Sale+OE | $19.17 | -16.7K | 17.0K | -50% | -$319.6K |
| D | 2024-01-04 | 2024-01-02 | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -16.7K | 4,014 | -81% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2024-01-02 | M | A | 16,670 | $13.88 | 33,675 | D | — | — | |
| 2 | Common | Class A Common Share | 2024-01-02 | S | D | 16,670 | $19.17 | 17,005 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $19.13 to $19.43. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Derivative | Share Option | 2024-01-02 | M | D | 16,670 | $0.00 | 4,014 | D | $13.88 · — to 2028-08-05 | 16,670 Class A Common Share | (F3) This option is fully vested and exercisable. |